Federal Circuit Upholds Rejection, Says Stent Patent Is Obvious

Mealey's (January 4, 2017, 11:18 AM EST) -- WASHINGTON, D.C. — Finding no error in a ruling by the Patent Trial and Appeal Board that invalidated, on obviousness grounds, 22 claims of a patented method of maintaining drugs delivered...
To view the full article, register now.